Vertex Pharmaceuticals Other Non-Current Liabilities 2010-2025 | VRTX
Vertex Pharmaceuticals other non-current liabilities for the quarter ending March 31, 2025 were $0.952B, a 11.52% increase year-over-year.
- Vertex Pharmaceuticals other non-current liabilities for 2024 were $0.902B, a 2.75% increase from 2023.
- Vertex Pharmaceuticals other non-current liabilities for 2023 were $0.878B, a 27.98% increase from 2022.
- Vertex Pharmaceuticals other non-current liabilities for 2022 were $0.686B, a 126.11% increase from 2021.